Tacrolimus-Induced Reversible Cerebral Vasoconstriction Syndrome with Delayed Multi-Segmental Vasoconstriction
- 1 May 2017
- journal article
- case report
- Published by Elsevier BV in Journal Of Stroke & Cerebrovascular Diseases
- Vol. 26 (5), e75-e77
- https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.03.006
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Two rare neurologic complications after heart transplantation: Posterior reversible encephalopathy syndrome, followed by reversible cerebral vasoconstriction syndromeThe Journal of Heart and Lung Transplantation, 2016
- Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signalingScientific Reports, 2016
- Reversible Cerebral Vasoconstriction Syndrome, Part 2: Diagnostic Work-Up, Imaging Evaluation, and Differential DiagnosisAmerican Journal Of Neuroradiology, 2015
- Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical CourseAmerican Journal Of Neuroradiology, 2015
- A Novel Approach to Diagnose Reversible Cerebral Vasoconstriction Syndrome: A Case SeriesJournal Of Stroke & Cerebrovascular Diseases, 2015
- Reversible cerebral vasoconstriction syndrome resulted in cerebral infarction after allogeneic stem cell transplantation: a case reportAnnals of Hematology, 2013
- Reversible cerebral vasoconstriction syndromeThe Lancet Neurology, 2012
- The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patientsBrain, 2007